Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexgenia is a life sciences company that specializes in the development of stimuli-responsive "smart" polymers for diagnostic and research applications. The company's platform technology enables the rapid and efficient separation of target molecules from complex biological samples, significantly enhancing the sensitivity and speed of diagnostic assays. By utilizing polymers that transition between soluble and insoluble states in response to environmental triggers like temperature, Nexgenia provides innovative solutions for protein purification and clinical diagnostics. The company was founded based on research from the University of Washington and was later acquired by Thermo Fisher Scientific to bolster its sample preparation and diagnostic portfolios. Its technology is particularly valued for its ability to improve the performance of magnetic bead-based assays and point-of-care testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexgenia.